臨床試驗

ColoSeal™ ICD System Safety and Feasibility Studies

NCT：NCT06402188 · ACTIVE_NOT_RECRUITING

NCT IDNCT06402188

狀態ACTIVE_NOT_RECRUITING

開始日期2023-06-05

完成時間2027-03-31

SponsorAverto Medical, Inc. (INDUSTRY)

First posted2024-05-07

Last updated2026-09-10

簡要摘要

The studies aim to evaluate the safety and feasibility of the ColoSeal Intraluminal Colonic Diversion (ICD) System in two prospective, multicenter, single-arm studies. The ColoSeal ICD System is intended to be used to protect a damaged segment of colon such as a surgical anastomosis, anastomosis leak, or perforation from contact with fecal flow for up to 14 days. The device will be evaluated in adult patients with rectal and rectosigmoid cancer undergoing a resection with a colorectal anastomosis.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。